Written Question·Department of Health and Social Care·UIN 62829

Restless Legs Syndrome: Medical Treatments

Tabled: 25 June 2025

Answered: 3 July 2025

Question

Adam Dance

To ask the Secretary of State for Health and Social Care, what assessment NHS England has made of the potential risks of dopamine agonists as a treatment for restless leg syndrome.

Answer

Karin Smyth

NHS England has made no assessment. The Medicines and Healthcare products Regulatory Agency (MHRA) assesses all medicines before they are licensed in the United Kingdom, with regard to quality, safety, and efficacy. The licensed dopamine agonist medicines...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 62829) →